ToffCap’s Monday Monitor #75Zevra Therapeutics, Inc. – ZVRA
Pitch Summary: Zevra Therapeutics has strong insider buying and recently completed a significant asset sale, positioning it for reduced cash burn and future profitability. BSD Analysis: The insider buying at Zevra Therapeutics, combined with the sale of its Pediatric Rare Disease Priority Review Voucher, highlights confidence in the company’s financial health and strategic direction. The […]
